Pub. Date : 2021 Sep
PMID : 34586105
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The current first-line regimen for the treatment of DLBCL is R-CHOP, which is the combination of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. | Doxorubicin | DNA damage inducible transcript 3 | Homo sapiens |